Skip to main content
. 2017 Nov 2;14(1):27–33. doi: 10.5152/iao.2017.3825

Table 1.

Mean hearing thresholds in ABR test (ABR mean dB ± standard deviation)

Groups Day 0 Day 4 Day 8
Group I (Control Group) 10.50±4.37 10.50±5.50 11.00±4.18
Group II (Cisplatin group) 10.00±4.08 16.50±3.37a 25.00±3.53ab
Group III (Cisplatin + Cortexin group) 9.50±4.97 13.50±3.37 16.00±2.23c

The variables were expressed as mean±standard deviation.

a

Compared to the Control group, Cisplatin group had significantly elevated hearing thresholds on the 4th and the 8th days (p<0.05).

b

Cisplatin group had significantly elevated hearing threshold on the 8th day compared to the 4th day (p<0.05).

c

Comparison of the mean hearing thresholds of Cisplatin+Cortexin group and Cisplatin group on the 8th day indicated that there was a significant decrease in the Cisplatin+Cortexin group (p<0.05).

ABR: auditory brainstem response